AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

714.764

-4.169-0.58%

Number of Gainers:17

Number of Losers:11

Number of Flat:17

PE:- -

High:721.437

Open:718.050

Low:714.076

Close:718.933

Volume:43.02M

Turnover:249.64M

Market Cap:108.28B

Float Cap:105.14B

Loading ...

Actinogen Achieves Agreement With the FDA in a Type C Meeting on the Manufacturing, Clinical and Nonclinical Activities Required for a Future US Marketing Approval of Xanamem for Alzheimer’s Disease

THOMSON REUTERS

Actinogen: FDA Agreed for Only One Additional, Pivotal Trial Using a Single 10 Mg Xanamem Dose Design VS. Placebo for Alzheimer's Trial

THOMSON REUTERS

Actinogen Medical Ltd - Meeting With European Medicines Agency for Alzheimer’s Disease Scheduled for 2026

THOMSON REUTERS

Altcoin season nears critical threshold as top tokens fuel rally

Opthea Limited Publishes 2024-2025 Annual Report

ASX Midday Sector Update: Energy Stocks Up, Healthcare Declines

MT Newswires Live

BRIEF-Bioxyne Ltd Received Import Authorisations Medical Cannabis Products

Bioxyne Ltd - Received Import Authorisations From German Government for 1,550Kg of Medical Cannabis Products

THOMSON REUTERS

A Look at Botanix Pharmaceuticals (ASX:BOT) Valuation Following South Korea ECCLOCK Gel Approval

Simply Wall St.

Dimerix Drug's Potential 'Overlooked' By Australian Market, Says Euroz Hartleys

MT Newswires Live

Growth - the defining factor this reporting season

Schroders warn of frothy markets despite ASX highs

CitiFirst CSL SFI MINIs Dividend Final Amount-CTW

ASX reporting season: Margins, misses, and market opportunities

PolyNovo Requests Trading Halt Ahead of NovoSorb Device Trial Results in Neuroischemic Diabetic Wounds

MT Newswires Live

BRIEF-Polynovo Seeks Trading Halt

Polynovo Ltd - Seeks Trading Halt Due to Clinical Trial Results on Novosorb Btm

THOMSON REUTERS

PolyNovo Limited (ASX:PNV) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable

Simply Wall St.

ASX Midday Sector Update: Real Estate Stocks Jump, Healthcare Falls

MT Newswires Live

Thailand Launches Official Host Country Website for the 2026 IMF- World Bank Group Annual Meetings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":714.76434,"timestamp":1758175199611,"preClose":718.9331,"halted":0,"volume":43024083,"delay":0,"changeRate":-0.005799,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-4.168762,"latestTime":"09-18 16:00:00 AEST","open":718.05005,"high":721.43744,"low":714.0763,"amount":249638907,"amplitude":0.010239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1758240000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1758153600000,1758175200000]],"turnoverRate":0.00154,"increases":20,"decrements":13,"flats":11,"marketCap":108275111949.75,"floatMarketCap":105142501769.4375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":721.43744,"amplitude":0.010239,"preClose":718.9331,"low":714.0763,"latestPrice":714.76434,"volume":43024083,"delay":0,"open":718.05005,"prevYearClose":936.801,"prevWeekClose":740.889,"prevMonthClose":762.058,"prevQuarterClose":795.022,"fiveDayClose":733.285,"twentyDayClose":798.289,"sixtyDayClose":793.519,"secType":"PLATE","market":"AU","turnoverRate":0.00154,"marketCap":108275111949.75,"floatMarketCap":105142501769.4375,"timestamp":1758175199611,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":17,"down":11,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2567489111","title":"Actinogen Achieves Agreement With the FDA in a Type C Meeting on the Manufacturing, Clinical and Nonclinical Activities Required for a Future US Marketing Approval of Xanamem for Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2567489111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567489111?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:30","pubTimestamp":1757939400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUAC34YFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","ACW.AU","BK7067"],"gpt_icon":0},{"id":"2567323114","title":"Actinogen: FDA Agreed for Only One Additional, Pivotal Trial Using a Single 10 Mg Xanamem Dose Design VS. Placebo for Alzheimer's Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2567323114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567323114?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:30","pubTimestamp":1757939400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUAC34YFN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","ACW.AU","BK7508"],"gpt_icon":0},{"id":"2567114396","title":"Actinogen Medical Ltd - Meeting With European Medicines Agency for Alzheimer’s Disease Scheduled for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2567114396","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567114396?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:30","pubTimestamp":1757939400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nTUAC34YFN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACW.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2567919244","title":"Altcoin season nears critical threshold as top tokens fuel rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2567919244","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567919244?lang=en_us&edition=fundamental","pubTime":"2025-09-15 16:51","pubTimestamp":1757926300,"startTime":"0","endTime":"0","summary":"Altcoins are heating up as the Altcoin Season Index surges closer to the altseason threshold. However, a market analyst has issued a serious warning.The Altcoin Season Index has surged to 72, nearing the critical 75 level that signals full altseason.Solana led large-cap gainers, rising 17% in the past week and overtaking Binance Coin in market cap.Analyst Maartunn warns of parallels with December 2024’s market correction, urging investors to stay alert and manage risk carefully.The altcoin season is approaching a key inflection point. Following a massive uptick to 68 last week, the Altcoin Season Index now sits at 72, just shy of the 75 level that officially signals an “altseason.” This development has ignited fresh excitement among traders, especially as several large-cap altcoins are beginning to show strong performance.He also likened the situation to a game of musical chairs when the music stops, not everyone will be sitting comfortably. While the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/altcoin-season-nears-critical-threshold-as-top-tokens-fuel-rally/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/altcoin-season-nears-critical-threshold-as-top-tokens-fuel-rally/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["BTC.USD.CC","ETH","BK4519","BK4585","BK7096","BK4220","BTC.AU","SOL.AU","ETH.USD.HKCC","BK7508","BK4588","MYX.AU","ETH.USD.CC","SOL","BK7083","BK7016","SOL.USD.HKCC","BTC","BK4129","ADA.AU","METHmain","BTC.USD.HKCC","BK4601","BK7105","BK4103"],"gpt_icon":0},{"id":"2567819121","title":"Opthea Limited Publishes 2024-2025 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2567819121","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567819121?lang=en_us&edition=fundamental","pubTime":"2025-09-15 16:19","pubTimestamp":1757924379,"startTime":"0","endTime":"0","summary":"Opthea Limited has published its 2024-2025 Annual Report, highlighting significant developments over the past year. The report marks a turning point for the company, with a focus on leveraging scientific understanding of VEGF-C and D biology to develop innovative medicines. Despite promising Phase 2 data, the company's two Phase 3 clinical trials, COAST and ShORe, evaluating sozinibercept  for the treatment of wet age-related macular degeneration, did not meet their primary and secondary endpoints. This outcome has led Opthea to enter cash preservation mode, resulting in a reduction of its team and several Board members stepping down. The company's management reaffirms its commitment to supporting and growing innovations originating in Australia, while acknowledging the heightened risks in the biotech sector. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL4lnr4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPT.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2567419405","title":"ASX Midday Sector Update: Energy Stocks Up, Healthcare Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2567419405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567419405?lang=en_us&edition=fundamental","pubTime":"2025-09-15 11:30","pubTimestamp":1757907014,"startTime":"0","endTime":"0","summary":"Energy stocks advanced 0.5% at midday Monday, as investors look out for easing of the monetary policy in the US this week.Condor Energy  said a gas market and commercialization study for its Piedra Redonda gas field offshore Peru confirmed multiple pathways to monetization and identified immediate local and regional market opportunities, including gas-to-power and compressed natural gas supply to northern Peru and Ecuador.Meanwhile, healthcare fell more than 1%.Avita Medical  said it received the CE Mark approval under the European Union Medical Device Regulation for Recell GO, its burn and wound recovery medical product. It said that it will now begin commercialization of Recell GO in select European countries, including Germany, Italy, and the UK.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CND.AU","BK7508","BK7067","BK7142","HCSG","AVH.AU","BK4137"],"gpt_icon":0},{"id":"2567169743","title":"BRIEF-Bioxyne Ltd Received Import Authorisations Medical Cannabis Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2567169743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567169743?lang=en_us&edition=fundamental","pubTime":"2025-09-15 09:35","pubTimestamp":1757900102,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Ltd Received Import Authorisations Medical Cannabis ProductsSept 15 (Reuters) - Bioxyne Ltd BXN.AX:RECEIVED IMPORT AUTHORISATIONS FROM GERMAN GOVERNMENT FOR 1,550KG OF MEDICAL CANNABIS PRODUCTSFurther company coverage: BXN.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nFWN3UZ0IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","BXN.AU","BK7508"],"gpt_icon":0},{"id":"2567216336","title":"Bioxyne Ltd - Received Import Authorisations From German Government for 1,550Kg of Medical Cannabis Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2567216336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567216336?lang=en_us&edition=fundamental","pubTime":"2025-09-15 07:06","pubTimestamp":1757891186,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250914:nFWN3UZ0IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BXN.AU","BK7508"],"gpt_icon":0},{"id":"2567131158","title":"A Look at Botanix Pharmaceuticals (ASX:BOT) Valuation Following South Korea ECCLOCK Gel Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2567131158","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567131158?lang=en_us&edition=fundamental","pubTime":"2025-09-14 02:18","pubTimestamp":1757787484,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals (ASX:BOT) is on the radar this week after its partner Dongwha Pharm secured a regulatory green light for ECCLOCK gel in South Korea, paving the way for a commercial launch in early 2026. This approval is not just another piece of good news for Botanix. It is a meaningful step in its push to grow outside Australia, with the company poised to collect a share of royalties from future sales. Investors tracking Botanix have been waiting for a sign that the company’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-following","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bot/botanix-pharmaceuticals-shares/news/a-look-at-botanix-pharmaceuticals-asxbot-valuation-following","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7502","BK7096","BK7508","BOT.AU"],"gpt_icon":0},{"id":"2566518923","title":"Dimerix Drug's Potential 'Overlooked' By Australian Market, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2566518923","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566518923?lang=en_us&edition=fundamental","pubTime":"2025-09-12 14:24","pubTimestamp":1757658249,"startTime":"0","endTime":"0","summary":"Dimerix's  focal segmental glomerulosclerosis drug DMX-200's \"blockbuster potential\" is being overlooked by the Australian market, said Euroz Hartleys in a Friday note.The research firm added that over the next 24 months, US development milestones alone could deliver AU$119 million in payments, with a further $56 million tied to first sales, which, combined with existing cash, represents above 80% of Dimerix's current market cap in cash.Euroz Hartleys has maintained its speculative buy rating with an unchanged price target of AU$1.68.The company's shares rose 11% in Friday's close of trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","XKO.AU","XJO.AU","BK7501","XAO.AU","DXB.AU"],"gpt_icon":0},{"id":"2566928683","title":"Growth - the defining factor this reporting season","url":"https://stock-news.laohu8.com/highlight/detail?id=2566928683","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566928683?lang=en_us&edition=fundamental","pubTime":"2025-09-12 13:49","pubTimestamp":1757656195,"startTime":"0","endTime":"0","summary":"The FY25 reporting season has once again reinforced one of my long-held beliefs: in this market, growth remains the defining factor. The companies that delivered genuine revenue growth were rewarded, while those that disappointed were heavily punished. But growth alone is not enough. What the market now demands is that top-line growth ultimately translates into bottom-line earnings and margin expansion.Shareholders want to see that the investments companies make in building scale, technology, or distribution eventually generate earnings power. That is where the real shareholder value lies.A standout example this season was Seek . For years, Seek delivered consistent top-line expansion, but profitability lagged as management poured resources into new platforms and regional expansion. Investors tolerated this for a time, but patience was wearing thin. This reporting season changed the story: Seek’s top-line momentum finally came through in the bottom line. Earnings leveraged off prior in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/growth-the-defining-factor-this-reporting-season","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/growth-the-defining-factor-this-reporting-season","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["EVN.AU","BK7002","BK7501","BK7507","XKO.AU","BK7095","XJO.AU","BK7504","BK7506","BK7508","BK7067","CSL.AU","BK7082","SEK.AU","BK7104","WOW.AU","BK7503","COL.AU","BK7016","BK7040","XAO.AU","WTC.AU","IGO.AU","BK7511"],"gpt_icon":0},{"id":"2566928581","title":"Schroders warn of frothy markets despite ASX highs","url":"https://stock-news.laohu8.com/highlight/detail?id=2566928581","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566928581?lang=en_us&edition=fundamental","pubTime":"2025-09-12 13:40","pubTimestamp":1757655635,"startTime":"0","endTime":"0","summary":"August delivered one of the more remarkable months for Australian investors. Despite another season of patchy earnings - including disappointing results from blue-chip stalwarts such as CSL Limited  and James Hardie  - the ASX smashed through 9,000 points, rising 3% in the month. Small caps performed even better.At first glance, this strength might suggest a market underpinned by robust fundamentals. But as Martin Conlon, Head of Australian Equities at Schroders, and his deputy Andrew Fleming point out, the reality is very different.Momentum investing and quant-driven strategies are dictating short-term price moves, while fundamentals are often relegated to the back seat. For patient investors, this may be unsettling - but it also creates opportunity.In Schroder's webinarBroadcast Australian Equities: It's only a flesh wound, Conlon and Fleming unpack the sharp share price swings seen during reporting season. They separate justified moves from overreactions, highlight opportunities ari","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/schroders-warn-of-frothy-markets-despite-asx-highs","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/schroders-warn-of-frothy-markets-despite-asx-highs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["XKO.AU","BK7508","WOW.AU","BXB.AU","CSL.AU","BK7064","RMD.AU","ORG.AU","BK7135","BK7511","BK7007","CBA.AU","XAO.AU","BK7130","COL.AU","BK7006","XJO.AU","BK7507","BK7067","BK7044","JHX.AU","BK7040","BK7082","BK7501"],"gpt_icon":0},{"id":"2566777940","title":"CitiFirst CSL SFI MINIs Dividend Final Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2566777940","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566777940?lang=en_us&edition=fundamental","pubTime":"2025-09-12 13:24","pubTimestamp":1757654644,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250912:nASX2wjfS3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nASXbQbGln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","CSL.AU","BK7508"],"gpt_icon":0},{"id":"2566947598","title":"ASX reporting season: Margins, misses, and market opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2566947598","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566947598?lang=en_us&edition=fundamental","pubTime":"2025-09-12 12:06","pubTimestamp":1757649998,"startTime":"0","endTime":"0","summary":"First Sentier Investors' David Wilsonand Christian Guerra unpack August’s reporting season — the most volatile on record. From banks and insurers to industrials and hidden tech plays, they explore what moved the market and why volatility might be here to stay.With me today is  Christian Guerra, Head of Research for the Australian Equities Growth Team, and David Wilson, Deputy Head of the Team and Portfolio Manager for one of the longest running Australian Geared Equity Strategies. Welcome, Christian and David.The other thing that we thought was really pleasing was that dividends actually beat expectations by about 15%, and that was a combination of both stronger earnings as well as modestly higher payout ratios. We also saw special dividends from the likes of JB HiFi , Wesfarmers and Qantas . Now having said that, I did use the word encouraging. We probably just need to temper our enthusiasm a little bit, and I say that for two key reasons. Fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/asx-reporting-season-margins-misses-and-market-opportunities","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/asx-reporting-season-margins-misses-and-market-opportunities","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["JHX.AU","SUN.AU","SHL.AU","JBH.AU","BK7130","BK7507","WOW.AU","BK7040","XKO.AU","XJO.AU","BK7034","BK7153","PME.AU","BK7508","BXB.AU","BK7016","BK7511","BK7001","BK7064","ORG.AU","BK7124","BK7044","WTC.AU","BK7501","XAO.AU","BK7094","BK7007","BK7503","IAG.AU","BK7082","BK7006","QBE.AU","WES.AU","QAN.AU","COL.AU","CSL.AU","BK7067","RMD.AU","BK7030","BK7041"],"gpt_icon":0},{"id":"2566294468","title":"PolyNovo Requests Trading Halt Ahead of NovoSorb Device Trial Results in Neuroischemic Diabetic Wounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2566294468","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566294468?lang=en_us&edition=fundamental","pubTime":"2025-09-12 11:13","pubTimestamp":1757646805,"startTime":"0","endTime":"0","summary":"PolyNovo  requested a trading halt for its securities on Friday in respect of a poster made public on the results of a chronic wound investigator-initiated clinical trial comparing the use of NovoSorb biodegradable temporizing matrix device combined with negative pressure wound therapy with the clinical standard-of-care in subjects with neuroischemic diabetic wounds, according to a same-day Australian bourse filing.NovoSorb is a synthetic, biodegradable device designed to facilitate the growth of skin tissue within a patented polyurethane matrix.The medical technology company requested the trading halt to remain in place until the release of an announcement or the opening of the market on Sept. 16.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","PNV.AU","BK7508"],"gpt_icon":0},{"id":"2566481239","title":"BRIEF-Polynovo Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2566481239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566481239?lang=en_us&edition=fundamental","pubTime":"2025-09-12 08:21","pubTimestamp":1757636509,"startTime":"0","endTime":"0","summary":"BRIEF-Polynovo Seeks Trading HaltSept 12 (Reuters) - Polynovo Ltd PNV.AX:SEEKS TRADING HALT DUE TO CLINICAL TRIAL RESULTS ON NOVOSORB BTMFurther company coverage: PNV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UY0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PNV.AU","BK7508","BK7126"],"gpt_icon":0},{"id":"2566489729","title":"Polynovo Ltd - Seeks Trading Halt Due to Clinical Trial Results on Novosorb Btm","url":"https://stock-news.laohu8.com/highlight/detail?id=2566489729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566489729?lang=en_us&edition=fundamental","pubTime":"2025-09-12 08:20","pubTimestamp":1757636445,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UY0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","BK7508","PNV.AU"],"gpt_icon":0},{"id":"2566919910","title":"PolyNovo Limited (ASX:PNV) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable","url":"https://stock-news.laohu8.com/highlight/detail?id=2566919910","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566919910?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:34","pubTimestamp":1757622842,"startTime":"0","endTime":"0","summary":"The PolyNovo Limited ( ASX:PNV ) share price has done very well over the last month, posting an excellent gain of 26...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/polynovo-limited-asxpnv-stocks-shoot-up-26-but-its-pe-still","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/polynovo-limited-asxpnv-stocks-shoot-up-26-but-its-pe-still","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PNV.AU","BK7508","BK7126"],"gpt_icon":0},{"id":"2566893012","title":"ASX Midday Sector Update: Real Estate Stocks Jump, Healthcare Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2566893012","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566893012?lang=en_us&edition=fundamental","pubTime":"2025-09-11 11:32","pubTimestamp":1757561560,"startTime":"0","endTime":"0","summary":"Real estate stocks jumped a little over 1% at midday Thursday. US wholesale inflation declined in August, boosting expectations of a US Federal Reserve rate cut.Elanor Commercial Property Fund (ASX:EC","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7122","PNV.AU","BK7126","BK7508","CFA.SI","ECF.AU","BK7154","HCSG","BK4137"],"gpt_icon":0},{"id":"2566930529","title":"Thailand Launches Official Host Country Website for the 2026 IMF- World Bank Group Annual Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2566930529","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566930529?lang=en_us&edition=fundamental","pubTime":"2025-09-11 11:11","pubTimestamp":1757560260,"startTime":"0","endTime":"0","summary":"BANGKOK, Sept. 11, 2025 /PRNewswire/ -- Thailand, through the Ministry of Finance  and the Bank of Thailand  is actively building momentum as the host of the 2026 Annual Meetings of the International Monetary Fund  and the World Bank Group  from 12–18 October 2026, at the Queen Sirikit National Convention Center in Bangkok. This landmark event marks Thailand's distinguished return as the host after 35 years, reinforcing the nation's unwavering commitment to fostering global cooperation and sustainable development within the international financial community.The country's strategic location, rich culture, renowned tourism, and modern infrastructure affirm its exceptional capability to host this pivotal conference. Beyond fostering global economic discussions on global economic and financial landscapes, the meetings offer delegates an unparalleled chance to experience Thailand's hospitality and unique cultural tapestry, thereby elevating the nation's international standing.Thailand as Ho","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2769813/IMG_3819__1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2769813/IMG_3819__1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/thailand-launches-official-host-country-website-for-the-2026-imf-world-bank-group-annual-meetings-302553431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMF","BK4181","HST","BK7096","BK7508","BK4218","BK7502","BK4585","BOT.AU","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":75,"code":"91000000","status":"200"}]}}